{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:48:23Z","timestamp":1754164103432,"version":"3.41.2"},"reference-count":23,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["NIHR201085"],"award-info":[{"award-number":["NIHR201085"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2023,8,1]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To assess the real-world evidence for flash glucose monitoring (Abbott FreeStyle Libre) for children with type 1 diabetes in terms of glucose control, secondary healthcare resources and costs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>We conducted a controlled before and after study (approximately 12\u2009months before and after) using routinely collected health record data on children who start using flash monitors and a control population of children with self-monitoring of blood glucose (SMBG). Our population-based sample of eligible individuals using flash monitoring (n=114) and controls (n=80) aged between 4 and 18 years was drawn from four paediatric diabetes clinics (secondary care) in the South West England. Outcome measures included: glycated hemoglobin (HbA1c), frequency of BG tests; frequency of sensor scans; time in recommended glucose range; short-term complications (hypoglycemia, diabetic ketoacidosis and related illness resulting in investigation) and secondary care costs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>After adjustment for age, time since diagnosis, deprivation and the test modality (point of care or laboratory), the mean HbA1c reading for controls was 61.2 (mmol\/mol) for the period before and 63.9 after. For individuals using flash monitoring, the adjusted mean HbA1c reading was 64.6 for the period before implementation and 63.8 after. Rates of short-term complications were low across all groups in the study. Whereas the \u2018after\u2019 flash monitoring group had substantially higher incremental costs (+\u00a3703 vs the flash monitoring \u2018before\u2019 comparison and +\u00a3841 vs contemporaneous SMBG controls), these cost differences were driven by primary care prescribing (sensor costs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>There was some indication that flash monitoring might help young people improve the control of their diabetes but for our sample, the difference between finger-prick testing and flash monitoring was not clinically significant (HbA1c improvement &lt;5 mmol\/mol). Given the pace of technological change within diabetes, research efforts should now facilitate the real-time analysis of long-term routine data on flash and continuous glucose monitors.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2023-003561","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:55:16Z","timestamp":1693227316000},"page":"e003561","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of flash glucose monitoring in four pediatric diabetes clinics: controlled before and after study to produce real-world evidence of patient benefit"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-9536","authenticated-orcid":false,"given":"Rebecca","family":"Kandiyali","sequence":"first","affiliation":[{"name":"Centre for Health Economics, Warwick Medical School, Coventry, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel","family":"Taylor","sequence":"additional","affiliation":[{"name":"Research and Development, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Thomas","sequence":"additional","affiliation":[{"name":"Bristol Paediatric Diabetes, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freyja","family":"Cullen","sequence":"additional","affiliation":[{"name":"Bristol Paediatric Diabetes, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hollingworth","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2366-008X","authenticated-orcid":false,"given":"Jenny","family":"Ingram","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie","family":"Kenward","sequence":"additional","affiliation":[{"name":"North Somerset and South Gloucestershire Integrated Care Board, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol","family":"West","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Great Western Hospitals NHS Foundation Trust, Swindon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"McGregor","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Royal Devon and Exeter Foundation Trust, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Hospitals Plymouth NHS Trust, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Hamilton-Shield","sequence":"additional","affiliation":[{"name":"Bristol Paediatric Diabetes, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"},{"name":"NIHR Bristol Biomedical Research Centre, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"2025073112513271000_11.4.e003561.1","unstructured":"RCPCH, Health Policy Team . The case for investing in children and young people\u2019s diabetes services. 2019. Available: https:\/\/www.rcpch.ac.uk\/resources\/case-investing-children-young-peoples-diabetes-services [Accessed 14 May 2019]."},{"key":"2025073112513271000_11.4.e003561.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03698.x"},{"key":"2025073112513271000_11.4.e003561.3","doi-asserted-by":"crossref","unstructured":"NICE . NICE guideline [Ng18]. diabetes (type 1 and type 2) in children and young people: diagnosis and management; 2016.","DOI":"10.12968\/indn.2016.8.18"},{"key":"2025073112513271000_11.4.e003561.4","unstructured":"Diabetes UK . Diabetes UK consensus guideline for flash glucose monitoring. 2017. Available: https:\/\/www.diabetes.org.uk\/resources-s3\/2017-09\/1190Flash20glucosemonitoringguidelineSBV94.pdfga2.137083376.1339632840.1505301182-2056973880.1505301182 [Accessed 04 Jun 2019]."},{"key":"2025073112513271000_11.4.e003561.5","unstructured":"NICE . NICE guideline [NG18]. diabetes (type 1 and type 2) in children and young people: diagnosis and management. 2022. Available: https:\/\/www.nice.org.uk\/guidance\/NG18"},{"key":"2025073112513271000_11.4.e003561.6","unstructured":"NICE . Diabetes in children and young people. quality statement 4: continuous glucose monitoring in type 1 diabetes. 2016. Available: https:\/\/www.nice.org.uk\/guidance\/qs125\/chapter\/Quality-statement-4-Continuous-glucose-monitoring-in-type-1-diabetes [Accessed 04 Jun 2019]."},{"key":"2025073112513271000_11.4.e003561.7","unstructured":"Healthcare Improvement Scotland . Evidence note, number 81. What is the clinical and cost effectiveness of freestyle libre flash glucose monitoring for patients with diabetes mellitus treated with intensive insulin therapy? 2018. Available: http:\/\/www.healthcareimprovementscotland.org\/our_work\/technologies_and_medicines\/topics_assessed\/shtg_009-18.aspx [Accessed 19 Jul 2019]."},{"key":"2025073112513271000_11.4.e003561.8","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/pedi.12735","article-title":"Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study","volume":"19","author":"Campbell","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"2025073112513271000_11.4.e003561.9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ped.14412","article-title":"Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring-derived glycemic makers in children and adolescents with type 1 diabetes","volume":"63","author":"Suzuki","year":"2021","journal-title":"Pediatr Int"},{"key":"2025073112513271000_11.4.e003561.10","unstructured":"FLASH study team . Implementation of flash glucose monitoring in four paediatric diabetes clinics \u2013 before and after study to produce real world evidence of patient benefit. FLASH protocol 1.5. 2022. Available: https:\/\/research-information.bris.ac.uk\/en\/projects\/implementation-of-flash-glucose-monitoring-in-four-paediatric-dia"},{"key":"2025073112513271000_11.4.e003561.11","doi-asserted-by":"crossref","unstructured":"Kandiyali R , Taylor H . Implementation of flash glucose monitoring in four paediatric diabetes clinics \u2013 controlled before and after study to produce real world evidence of patient benefit. Statistical and health economic analysis plan. medRxiv 2022. doi:10.1101\/2022.11.22.22281186","DOI":"10.1101\/2022.11.22.22281186"},{"key":"2025073112513271000_11.4.e003561.12","unstructured":"Department of Health . National schedule of costs for NHS trusts and NHS foundation trusts. 2021. Available: https:\/\/www.england.nhs.uk\/costing-in-the-nhs\/national-cost-collection\/"},{"key":"2025073112513271000_11.4.e003561.13","unstructured":"NHS Business Services Authority . Drug tariff. 2019. Available: https:\/\/www.nhsbsa.nhs.uk\/pharmacies-gp-practices-and-appliance-contractors\/drug-tariff [Accessed 04 Jun 2019]."},{"key":"2025073112513271000_11.4.e003561.14","unstructured":"British National Formulary . 2020. Available: www.bnf.org\/bnf\/"},{"key":"2025073112513271000_11.4.e003561.15","unstructured":"NHS England . NHS to provide life changing glucose monitors for type 1 diabetes patients. 2018. Available: https:\/\/www.england.nhs.uk\/2018\/11\/nhs-to-provide-life-changing-glucose-monitors-for-type-1-diabetes-patients\/ [Accessed 14 May 2019]."},{"key":"2025073112513271000_11.4.e003561.16","unstructured":"FLASH study team . New animations report the views of young people using flash glucose monitoring for type 1 diabetes. 2022. Available: https:\/\/www.bristolbrc.nihr.ac.uk\/news\/new-animations-report-the-views-of-young-people-using-flash-glucose-monitoring-for-type-1-diabetes\/"},{"key":"2025073112513271000_11.4.e003561.17","first-page":"73","article-title":"Cost-effectiveness analysis of a flash glucose monitoring system for patients with type 1 diabetes receiving intensive insulin treatment in Sweden","volume":"14","author":"Bilir","year":"2018","journal-title":"Eur Endocrinol"},{"key":"2025073112513271000_11.4.e003561.18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabres.2018.01.028","article-title":"Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment","volume":"138","author":"Hellmund","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2025073112513271000_11.4.e003561.19","unstructured":"Bidonde J , Fagerlund BC , Fronsdal KB , et al . Freestyle libre flash glucose self-monitoring system: a single-technology assessment. NIPH Systematic Reviews; 2017."},{"key":"2025073112513271000_11.4.e003561.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002580","article-title":"Freestyle libre flash glucose monitoring system for people with type 1 diabetes in the UK: a budget impact analysis","volume":"10","author":"Blissett","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2025073112513271000_11.4.e003561.21","unstructured":"NHS England . Flash glucose monitoring: national arrangements for funding of relevant diabetes patients. Available: https:\/\/www.england.nhs.uk\/publication\/flash-glucose-monitoring-national-arrangements-for-funding-of-relevant-diabetes-patients\/ [Accessed 04 Jun 2019]."},{"key":"2025073112513271000_11.4.e003561.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2205650"},{"key":"2025073112513271000_11.4.e003561.23","unstructured":"NHS England . NHS to roll out life-changing glucose monitors to all type 1 diabetes patients. 2022."}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2023-003561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:51:43Z","timestamp":1753991503000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2023-003561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,28]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/bmjdrc-2023-003561"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2023-003561","relation":{},"ISSN":["2052-4897"],"issn-type":[{"type":"electronic","value":"2052-4897"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}